⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

November 24, 2025PatientOpen Access

Patient Insights on Acne Hyperpigmentation, Trifarotene, and Skincare: 6-Month, LEAP Phase 4 Qualitative Exit Interview Findings

Carla Dias Barbosa Natalie Taylor Kevin Chan Jean Philippe York Jorge Puelles Rajeev Chavda Carla Dias Barbosa Natalie Taylor Kevin Chan Jean Philippe York Jorge Puelles Rajeev Chavda

View Full Paper

Ask AI

Bookmark

Share

Abstract

All trifarotene-treated patients reported improvements in AIH and that their treatment expectations were met. Findings support that trifarotene plus a skincare regimen provides greater benefit in the improvement of AIH than its VC. However, VC plus a skincare regimen also appeared to improve patients' perceptions of their AIH.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Barbosa et al. (2025) studied this question.

synapsesocial.com/papers/6928f0f9a65b730b9ea799b8 https://doi.org/10.1007/s40271-025-00789-9

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Patient Insights on Acne Hyperpigmentation, Trifarotene, and Skincare: 6-Month, LEAP Phase 4 Qualitative Exit Interview Findings2025
2Importance of treating acne sequelae in skin of color: 6‐month phase <scp>IV</scp> study of trifarotene with an appropriate skincare routine including <scp>UV</scp> protection in acne‐induced post‐inflammatory hyperpigmentation2024 · 11 citations
3Efficacy of a new generation topical retinoid in the treatment of patients with moderate to severe acne on the face and trunk2024
4Trifarotene: a new chapter in the treatment of acne. An overview of the data on efficacy and safety profile of a fourth-generation retinoid2024 · 2 citations
5Trifarotene Administration in the Patient with Acne Conglobata and Autoimmune Hepatitis: Case Study2025